Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07XUC
|
|||
| Drug Name |
GSK2556286
|
|||
| Synonyms |
GSK2556286; UNII-J9U8H9VQV0; GSK-286; J9U8H9VQV0; GSK-2556286; 1210456-20-4; GSK286; 6-((4-(2,3-Dimethylphenoxy)-1-piperidinyl)methyl)-2,4(1H,3H)-pyrimidinedione; 2,4(1H,3H)-Pyrimidinedione, 6-((4-(2,3-dimethylphenoxy)-1-piperidinyl)methyl)-; 6-[[4-(2,3-dimethylphenoxy)piperidin-1-yl]methyl]-1H-pyrimidine-2,4-dione; CHEMBL4650308; SCHEMBL19380190; EX-A6180; MS-24944; HY-147017; CS-0514179; Z644646478
Click to Show/Hide
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Tuberculosis [ICD-11: 1B10-1B14] | Phase 1 | [1] | |
| Company |
GlaxoSmithKline
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H23N3O3
|
|||
| Canonical SMILES |
CC1=C(C(=CC=C1)OC2CCN(CC2)CC3=CC(=O)NC(=O)N3)C
|
|||
| InChI |
InChI=1S/C18H23N3O3/c1-12-4-3-5-16(13(12)2)24-15-6-8-21(9-7-15)11-14-10-17(22)20-18(23)19-14/h3-5,10,15H,6-9,11H2,1-2H3,(H2,19,20,22,23)
|
|||
| InChIKey |
AZOFJHATIPDIER-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04472897) A Randomised, Double Blind (Sponsor Unblinded), Placebo-controlled, First Time in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Oral Doses and the Food Effect of GSK2556286 in Healthy Adult Participants. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.